Lifshitz & Miller LLP Announces Investigation of Curaleaf Holdings, Inc., Granite Construction, Inc., Karyopharm Therapeutics, Inc., ProPetro Holdings Corp., SAExploration, Inc., Sunnova Energy International, Inc., and Surface Oncology, Inc.

NEW YORK, Sept. 17, 2019 /PRNewswire/ —

Curaleaf Holdings, Inc. (CURLF)

Lifshitz & Miller announces investigation into possible securities laws violation in connection with the FDA’s warning letter to Curaleaf stating that several of CURLF’s CBD products were “misbranded drugs” in violation of the Federal Food, Drug, and Cosmetic Act.

If you are a CURLF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Granite Construction, Inc. (GVA)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with GVA’s disclosure that second quarter 2019 financial results were negatively impacted by non-cash charges related to four civil joint venture projects.

If you are a GVA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Karyopharm Therapeutics, Inc.

Lifshitz & Miller announces investigation into possible securities laws violations in connection with Karyopharm false represented the safety and efficacy of selinexor, a pharmaceutical drug intended for the treatment of various types of cancer that Karyopharm was in the process of developing.

If you are a KPTI investor, and would like

Read More

Scroll to Top